Technical Intelligence & Insights
Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Aziridine. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111087344A discloses a green synthesis for diaziridine-amino acid conjugates. This report analyzes the scalable route for high-purity pharmaceutical intermediates.
Patent CN107522645B details a novel ruthenium-catalyzed [3+2] cycloaddition for polysubstituted pyrroles. This method offers mild conditions and broad substrate scope for pharmaceutical intermediates.
Patent CN107501153A reveals a novel two-step synthesis for trifluoroethyl aziridines. This method offers significant cost reduction and supply chain reliability for high-purity pharmaceutical intermediates.
Patent CN108689901B reveals a mild, base-mediated route to aziridines. This method offers high yields and safety advantages for pharmaceutical intermediate manufacturing.
Novel catalytic method using p-nitrobenzoic acid offers cost-effective synthesis of beta-amino esters with high regioselectivity for reliable API manufacturing.
Patent CN109096138B reveals a robust Pd-catalyzed route for alpha-amino ketones using 2H-aziridines, offering significant cost reduction in pharmaceutical intermediate manufacturing.
Patent CN107501153A introduces a cost-efficient method eliminating expensive reagents while enhancing supply chain reliability through scalable fluorinated intermediate production.
Discover how ruthenium-catalyzed 3+2 cycloaddition enables efficient, single-step pyrrole synthesis with 50-71% yields, reducing multi-step costs and supply chain risks for pharmaceutical intermediates.